Showing 1 - 13 results of 13 for search 'Vivek Roy', query time: 0.05s
Refine Results
-
1
Primary Cutaneous T-Cell Lymphoblastic Lymphoma: Case Report and Literature Review by Sharad Khurana, Manuel Beltran, Liuyan Jiang, Ernesto Ayala, Vivek Roy
Published 2019-01-01
Article -
2
Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Preliminary Efficac... by Saurav Das, Sikander Ailawadhi, Taimur Sher, Vivek Roy, Andre Fernandez, Ricardo D. Parrondo
Published 2023-10-01
Article -
3
Isolation, characterization, identification, genomics and analyses of bioaccumulation and biosorption potential of two arsenic-resistant bacteria obtained from natural environments by Vivek Roy, Barnan Kumar Saha, Samarpita Adhikary, Madhumita G. Chaki, Monalisha Sarkar, Ayon Pal
Published 2024-03-01
Article -
4
Use of KRD-PACE as Salvage Therapy in Aggressive, Relapsed/Bortezomib-Refractory Extramedullary Multiple Myeloma: A Report of Two Cases and Literature Review by Ricardo D. Parrondo, Vivek Roy, Taimur Sher, Victoria Alegria, Asher A. Chanan-Khan, Sikander Ailawadhi
Published 2020-01-01
Article -
5
A prospective study of the relationship between illness perception, depression, anxiety, and quality of life in hematopoietic stem cell transplant patients by Steven C. Ames, Lori Lange, Gretchen E. Ames, Michael G. Heckman, Launia J. White, Vivek Roy, James M. Foran
Published 2024-02-01
Article -
6
Loneliness, immunological recovery patterns, and health-related quality of life (HRQOL) outcomes in patients receiving hematopoietic stem cell transplantation by Lori J. Lange, Steven C. Ames, Gretchen E. Ames, Michael G. Heckman, Launia J. White, Vivek Roy, James M. Foran
Published 2024-01-01
Article -
7
-
8
The digital divide: Racial disparities in adoption and utilization of health information technology among patients with lymphoid cancers by Sikander Ailawadhi, Meghna Ailawadhi, Navnita Dutta, Ricardo D. Parrondo, Vivek Roy, Taimur Sher, Mizba Baksh, Ahsan Rasheed, Saurav Das, Andre J. Fernandez, Aneel Paulus, Asher A. Chanan‐Khan
Published 2023-09-01
Article -
9
Factors determining utilization of stem cell transplant for initial therapy of multiple myeloma by patient race: exploring intra-racial healthcare disparities by Sikander Ailawadhi, Yaw Adu, Ryan D. Frank, Saurav Das, David O. Hodge, Andre Fernandez, Caitlyn Flott, Jamie Elliott, Ricardo Parrondo, Taimur Sher, Vivek Roy, Asher A. Chanan-Khan
Published 2024-05-01
Article -
10
Impact of psychiatric comorbidities on health care utilization and cost of care in multiple myeloma by Shehzad Niazi, Ryan D. Frank, Mayank Sharma, Vivek Roy, Steve Ames, Teresa Rummans, Aaron Spaulding, Taimur Sher, Meghna Ailawadhi, Kirtipal Bhatia, Salman Ahmed, Winston Tan, Asher Chanan-Khan, Sikander Ailawadhi
Published 2018-05-01
Article -
11
Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma by Ricardo D. Parrondo, Betsy R. LaPlant, Jamie Elliott, Andre Fernandez, Caitlin J. Flott, Diedre Arrington, Dustin Chapin, Jade Brown, Saurav Das, Vivek Roy, Asher A. Chanan-Khan, Sikander Ailawadhi
Published 2024-09-01
Article -
12
Acquired Factor VII Deficiency Associated With Chronic Myeloid Leukemia Blast Crisis by Emily B. Wolf MD, David Li MD, Andre J. Fernandez MPAS, PA-C, Lindsay B. Gardner MD, Candido E. Rivera MD, Ewa M. Wysokinska MD, Marwan E. Shaikh MD, Han W. Tun MD, Vivek Roy MD, Muhamad Alhaj Moustafa MD
Published 2023-11-01
Article -
13
Efficacy, safety, and cost of mobilization strategies in multiple myeloma: a prospective, observational study by Binod Dhakal, Mei-Jei Zhang, Linda J. Burns, Xiaoying Tang, Christa Meyer, Lih-Wen Mau, Ajay K. Nooka, Edward Stadtmauer, Ivana N Micallef, Joseph McGuirk, Luciano Costa, Mark B. Juckett, Nina Shah, Richard E. Champlin, Saad Z. Usmani, Sherif S. Farag, Taiga Nishihori, Vivek Roy, Andrew Bodiford, Yvonne J. Barnes, Edward J. Drea, Parameswaran Hari, Mehdi Hamadani
Published 2023-01-01
Article